Aerkeven

ALNY on track to $263

Long
NASDAQ:ALNY   Alnylam Pharmaceuticals, Inc.
ALNY put in a new ATH as expected. A big bearish divergence played out after hitting the 1.618 fib extension plunging it all the way down to ~$155 and reaching oversold on the RSI. It resumed the uptrend as it followed a new trend line, which it broke as the S&P plunged on 3rd December. However, it seems to be recovering quickly and if it can break the important resistance around 178 and turn it into support it looks primed to retest ATH at ~$212 and continue towards the 2.618 fib at ~$263.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.